Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Global Medical Director – Gastroenterology Abbott | Established Pharmaceutical Division About Abbott At Abbott , we believe people live their fullest lives when they are healthy — physically, emotionally, and socially . As a global healthcare
Viking (NYSE: VIK) was founded in 1997 and provides destination-focused journeys on rivers, oceans and lakes around the world. Designed for curious travelers with interests in science, history, culture and cuisine, Chairman and CEO Torstein Hagen
The global franchise head Immunology is responsible for defining and executing the global Immunology Therapeutic Area strategy to maximize long-term franchise value and patient impact. This role leads the development of global brand strategies, ensures excellence
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
The Global Franchise Head Gastroenterology & Rare Disease is responsible for defining and executing the global Gastroenterology & Rare Disease Therapeutic Area Strategy to maximize long-term franchise value and patient impact. This role leads the development
Global Medical Director – Gastroenterology Abbott | Established Pharmaceutical Division About Abbott At Abbott, we believe people live their fullest lives when they are healthy — physically, emotionally, and socially. As a global healthcare leader with
The Head New Product Innovation steers the strategic vision, design, and execution of next-generation dental implant systems, prosthetic components, and integrated digital solutions. Bridge clinical dental trends with technical reality while ensuring strict compliance with global
Job Summary Accountable for contributing to the development of overall, cross‑functional programmes for a priority disease area or asset, shaping assets with strong commercial potential in line with therapeutic area priorities. Key Responsibilities Providing direction and functional expertise
Overview Accountable for contributing to developing overall, cross-functional programs of a priority disease area/asset, focused on shaping assets with strong commercial potential in line with TA priorities. (Global) Provides direction and functional expertise in a cross-functional disease area/asset
Sr. Director, Global Immunology Franchise Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets
As part of the European Operations Team, the Customer Operations Coordinator plays a central role in ensuring the smooth execution of commercial sales across the EMEA region. This role supports the full order lifecycle, manages customer
Growth Specialist Switzerland (m/f/d) Cochlears mission is to help people hear and be heard. As the global leader in implantable hearing solutions, Cochlear is dedicated to helping people with moderate to profound hearing loss experience a